Twist Bioscience Corp (TWST)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Sep 30
In fiscal 2025, Twist Bioscience Corp reported revenue of $376.57M, up 20.3% from the prior year. The company ran a net loss, with a net margin of -20.6%. It held $641.86M in total assets against $168.90M in total liabilities.
Key ratios (FY2025)
-36.2%
Operating margin
-20.6%
Net margin
-16.4%
Return on equity
+20.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $376.57M | $312.97M | $245.11M | $203.56M | $132.33M | $90.10M | $54.38M | $25.43M | $10.77M | — |
| Cost of Revenue | $185.57M | $179.62M | $155.38M | $119.33M | $80.62M | $61.41M | $47.43M | $32.19M | $24.02M | — |
| Operating Income | -$136.26M | -$220.83M | -$217.16M | -$234.78M | -$152.73M | -$140.08M | -$108.85M | -$70.56M | -$58.48M | — |
| Net Income | -$77.67M | -$208.73M | -$204.62M | -$217.86M | -$152.10M | -$139.93M | -$107.67M | -$71.24M | -$59.31M | — |
| EPS (Diluted) | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 | $-3.57 | — | — | — | — |
| Total Assets | $641.86M | $614.32M | $776.40M | $961.38M | $702.10M | $398.88M | $186.99M | $115.79M | — | — |
| Total Liabilities | $168.90M | $141.63M | $152.97M | $171.99M | $121.28M | $62.62M | $34.91M | $26.73M | — | — |
| Shareholders' Equity | $472.96M | $472.69M | $623.43M | $789.38M | $580.82M | $336.26M | $152.08M | -$201.42M | -$133.36M | -$76.61M |
| Cash & Equivalents | $183.05M | $226.32M | $286.47M | $378.69M | $465.83M | $93.67M | $46.73M | $80.76M | $31.23M | — |
| Operating Cash Flow | -$47.63M | -$64.09M | -$142.47M | -$124.39M | -$112.24M | -$142.25M | -$87.94M | -$66.16M | -$51.30M | — |
| Capital Expenditures | $28.00M | $5.08M | $27.78M | $101.86M | $27.06M | $9.87M | $14.76M | $3.69M | $6.59M | — |
| Shares Outstanding | 60.63M | 58.88M | 57.56M | 56.52M | 49.50M | 45.08M | 32.87M | 3.21M | — | — |